Biohaven Ltd. Derivative Liability, Noncurrent
Biohaven Ltd. (BHVN) had Derivative Liability, Noncurrent of $12.32 million as of 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DerivativeLiabilitiesNoncurrent · last filed 2024-11-12
- 2024-09-30: Derivative Liability, Noncurrent $12.32M.
- 2024-06-30: Derivative Liability, Noncurrent $12.18M.
- 2023-12-31: Derivative Liability, Noncurrent $0.00.
| Period end | Derivative Liability, Noncurrent |
|---|---|
| 2024-09-30 | $12.32M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $12.18M 10-Q · filed 2024-08-09 |
| 2023-12-31 | $0.00 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |